- Home
- TYL vs BNTX Comparison
TYL vs BNTX Comparison
Compare TYL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYL
- BNTX
- Stock Information
- Founded
- TYL 1966
- BNTX 2008
- Country
- TYL United States
- BNTX Germany
- Employees
- TYL N/A
- BNTX N/A
- Industry
- TYL Computer Software: Prepackaged Software
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TYL Technology
- BNTX Health Care
- Exchange
- TYL Nasdaq
- BNTX Nasdaq
- Market Cap
- TYL 27.2B
- BNTX 23.9B
- IPO Year
- TYL N/A
- BNTX 2019
- Fundamental
- Price
- TYL $628.37
- BNTX $120.69
- Analyst Decision
- TYL Strong Buy
- BNTX Strong Buy
- Analyst Count
- TYL 13
- BNTX 15
- Target Price
- TYL $642.62
- BNTX $143.50
- AVG Volume (30 Days)
- TYL 292.4K
- BNTX 1.0M
- Earning Date
- TYL 10-23-2024
- BNTX 11-04-2024
- Dividend Yield
- TYL N/A
- BNTX N/A
- EPS Growth
- TYL 47.95
- BNTX N/A
- EPS
- TYL 5.48
- BNTX N/A
- Revenue
- TYL $2,077,606,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- TYL $10.57
- BNTX N/A
- Revenue Next Year
- TYL $10.43
- BNTX N/A
- P/E Ratio
- TYL $114.93
- BNTX N/A
- Revenue Growth
- TYL 8.04
- BNTX N/A
- 52 Week Low
- TYL $397.80
- BNTX $76.53
- 52 Week High
- TYL $638.56
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- TYL 57.25
- BNTX 57.89
- Support Level
- TYL $612.92
- BNTX $116.73
- Resistance Level
- TYL $635.48
- BNTX $123.29
- Average True Range (ATR)
- TYL 11.87
- BNTX 4.70
- MACD
- TYL -0.56
- BNTX 0.54
- Stochastic Oscillator
- TYL 72.07
- BNTX 73.82
About TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.